4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-25-203537
Director bought 41,666 shares at an average $24.65 ($1,027,111)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PAUL STEVEN M Director | 2025-09-12 | Purchase | +28,284 | $24.50 | $692,947 | 28,284 | I |
| PAUL STEVEN M Director | 2025-09-12 | Purchase | +13,382 | $24.97 | $334,165 | 41,666 | I |
| Open-market purchases · 41,666 sh · avg $24.65 · $1,027,111 | |||||||
Loading xslF345X05/ownership.xml…